跳至主要内容
临床试验/DRKS00033547
DRKS00033547已完成Unknown

In vivo evaluation of hard gelatin and hypromellose capsule disintegration in fasted state after intake with different fluids by salivary caffeine method

Institut für Pharmazie, Abteilung Biopharmazie und Pharmazeutische Technologie0 个研究点目标入组 12 人开始时间: 2024年8月2日最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 64 Years(—)
性别
All

入选标准

  • Body Mass Index (BMI) between 18.0 and 29.99 kg/m²
  • Good health as evidenced by the results of the physical examination, which are judged by the responsible physician not to differ in a clinically relevant way from the normal state

排除标准

  • Current participation in any clinical study including the use of any investigational drugs at the time of enrollment, or within 5 half-lives of enrollment, whichever is longer; or longer if required by local regulations
  • known allergic reactions or food intolerance to the capsules or fluids ingredients
  • problems to swallow large capsules
  • gastrointestinal diseases and/or pathological findings, which might interfere with gastrointestinal motility and emptying processes
  • drug or alcohol addiction
  • smokers of 10 or more cigarettes per day
  • subjects who are on a diet which could affect gastrointestinal motility (e.g. vegan)
  • eating disorders e.g. anorexia, bulimia
  • lactating and pregnant women (positive urine test)
  • subjects suspected or known not to follow instructions
  • subjects who are unable to understand the written and verbal instructions, regarding the risks and inconveniences they will be exposed to as a result of their participation in the study
  • less than 2 weeks after last acute disease
  • less than 1 week after last blood donation

研究者

发起方
Institut für Pharmazie, Abteilung Biopharmazie und Pharmazeutische Technologie

相似试验